BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25655069)

  • 1. The Janus Faces of IL-6 in GN.
    Salama AD; Little MA
    J Am Soc Nephrol; 2015 Jul; 26(7):1480-2. PubMed ID: 25655069
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN.
    Luig M; Kluger MA; Goerke B; Meyer M; Nosko A; Yan I; Scheller J; Mittrücker HW; Rose-John S; Stahl RA; Panzer U; Steinmetz OM
    J Am Soc Nephrol; 2015 Jul; 26(7):1597-607. PubMed ID: 25655068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor necrosis factor (TNF) and interleukin-6 (IL-6) in patients with glomerulonephritis].
    Kacprzyk F; Chrzanowski W
    Pol Arch Med Wewn; 1996 Sep; 96(3):224-33. PubMed ID: 9122013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Suppressive effects of GTW treatment on infiltration of inflammatory cell in glomeruli in anti-Thy1.1 glomerulonephritis].
    Wan Y; Sun W; Che X; Yang H; Ge M; Dai W; Shimizu F
    Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(1):72-7. PubMed ID: 19382456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.
    Luque Y; Cathelin D; Vandermeersch S; Xu X; Sohier J; Placier S; Xu-Dubois YC; Louis K; Hertig A; Bories JC; Vasseur F; Campagne F; Di Santo JP; Vosshenrich C; Rondeau E; Mesnard L
    Kidney Int; 2017 May; 91(5):1146-1158. PubMed ID: 28111009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms.
    Odobasic D; Kitching AR; Tipping PG; Holdsworth SR
    Kidney Int; 2005 Aug; 68(2):584-94. PubMed ID: 16014035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biology of interleukin-6 in the 21st century.
    Rose-John S
    Semin Immunol; 2014 Feb; 26(1):1. PubMed ID: 24556601
    [No Abstract]   [Full Text] [Related]  

  • 8. Cln 3-requiring 9 is a negative regulator of Th17 pathway-driven inflammation in anti-glomerular basement membrane glomerulonephritis.
    Lee H; Lee JW; Yoo KD; Yoo JY; Lee JP; Kim DK; Chin HJ; Kim YS; Yang SH
    Am J Physiol Renal Physiol; 2016 Sep; 311(3):F505-19. PubMed ID: 27306982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
    Kitching AR; Tipping PG; Timoshanko JR; Holdsworth SR
    Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
    Tang WW; Feng L; Vannice JL; Wilson CB
    J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
    Liu Y; Liu A; Li H; Li C; Lin J
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1296-305. PubMed ID: 21490132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer.
    Haura EB; Livingston S; Coppola D
    Clin Lung Cancer; 2006 Jan; 7(4):273-5. PubMed ID: 16512982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-dependent regulatory T cells in GN.
    Wang M
    Nat Rev Nephrol; 2019 Nov; 15(11):662. PubMed ID: 31383998
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF; Zhang CQ; Yin Q; An N; Liu SY; Yang H
    J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell-derived IL-10 does not vitally contribute to the clinical course of glomerulonephritis.
    Kluger MA; Ostmann A; Luig M; Meyer MC; Goerke B; Paust HJ; Meyer-Schwesinger C; Stahl RA; Panzer U; Tiegs G; Steinmetz OM
    Eur J Immunol; 2014 Mar; 44(3):683-93. PubMed ID: 24227595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum and urinary interleukin-6 levels in patients with primary glomerulonephritis].
    Hrvacević R; Topalov D; Stojanović R; Lilić D; Dimitrijević J; Maksić Dj; Marić M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():40-2. PubMed ID: 9102925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Visualization of the interaction between IL-6 and IL-6R by imaging ellipsometry].
    Wang ZH; Jin G
    Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(1):99-101. PubMed ID: 11977610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification in the von Hippel-Lindau protein is involved in the progression of experimentally induced rat glomerulonephritis.
    Kudo Y; Kakinuma Y; Iguchi M; Sato T; Sugiura T; Furihata M; Shuin T
    Nephron Exp Nephrol; 2007; 106(3):e97-106. PubMed ID: 17519558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell endocytosis of the complex interleukin-6-soluble interleukin-6 receptor and its intralysosomal degradation].
    Korolenko TA; Heinrich PK; Hemmann U; Weiergraber O; Dittrich E; Graeve L
    Biull Eksp Biol Med; 1997 Nov; 124(11):527-9. PubMed ID: 9471247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.